Familial hypercholesterolaemia
KEYWORDS: people, diagnosis, quality, statement, data, treatment, testing, clinical, children, specialist, hypercholesterolaemia, familial hypercholesterolaemia, clinical diagnosis, familial, source

Ratio of observed to estimated numbers of people with FH, using an estimate based on the area's estimated prevalence of FH (based on 1 in 500) and population size. Data source: Local data collection using a dedicated database. What the quality statement means for different audiences Service providers ensure that systems are in place for people with a clinical diagnosis of FH to be referred for specialist assessment. Healthcare practitioners refer people with a clinical diagnosis of FH for specialist assessment. Commissioners ensure that they commission services that can offer specialist assessment for people with a clinical diagnosis of FH. People who are given a clinical diagnosis of FH because they have high cholesterol, family history or other signs are referred for specialist assessment. Source guidance Familial hypercholesterolaemia: identification and management. NICE guideline CG71 (2008, updated 2019), recommendations 1.2.2 and 1.3.1.17 Definitions of terms used in this quality statement Familial hypercholesterolaemia (FH) FH relates to heterozygous FH only. Clinical diagnosis of FH Assessment for a clinical diagnosis of FH should use all 3 criteria below: • exclusion of secondary causes of hypercholesterolaemia • 2 measurements of LDL-C concentration • assessment against Simon Broome or Dutch Lipid Clinic Network criteria to
